LncRNA mediated metabolic reprogramming: the chief culprits of solid tumor malignant progression: an update review

Abstract Metabolism reprogramming (MR) is one of the top ten hallmarks of malignant tumors. The aberrant activation of MR has been recognized as a critical contributory factor to the malignant progression of solid tumors. Moreover, various long non-coding RNAs (lncRNAs) are implicated in the aberran...

Full description

Saved in:
Bibliographic Details
Main Authors: Kun Fang, Huizhe Xu, Shuai Yuan, Xiaoxi Li, Xiaoyu Chen, Xiushi Fan, Xiaoxin Gao, Lu Zhang, Shulan Sun, Xudong Zhu
Format: Article
Language:English
Published: BMC 2024-11-01
Series:Nutrition & Metabolism
Subjects:
Online Access:https://doi.org/10.1186/s12986-024-00866-0
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850062408706424832
author Kun Fang
Huizhe Xu
Shuai Yuan
Xiaoxi Li
Xiaoyu Chen
Xiushi Fan
Xiaoxin Gao
Lu Zhang
Shulan Sun
Xudong Zhu
author_facet Kun Fang
Huizhe Xu
Shuai Yuan
Xiaoxi Li
Xiaoyu Chen
Xiushi Fan
Xiaoxin Gao
Lu Zhang
Shulan Sun
Xudong Zhu
author_sort Kun Fang
collection DOAJ
description Abstract Metabolism reprogramming (MR) is one of the top ten hallmarks of malignant tumors. The aberrant activation of MR has been recognized as a critical contributory factor to the malignant progression of solid tumors. Moreover, various long non-coding RNAs (lncRNAs) are implicated in the aberrant activation of MR in solid tumor cells. Therefore, in this review, we mainly focus on summarizing the functional relevance and molecular mechanistic underpinnings of lncRNAs in modulating MR of solid tumors by targeting glucose metabolism, lipid metabolism, affecting mitochondrial function, and regulating interactions between tumor and non-tumor cells in tumor microenvironment. Besides, we also underscore the potential for constructing lncRNAs-centered tumor metabolic regulation networks and developing novel anti-tumor strategies by targeting lncRNAs and abnormal MR. Ultimately, this review seeks to offer new targets and avenues for the clinical treatment of solid tumors in the future.
format Article
id doaj-art-cbd9ac043ef2425896d4bcfb865eeeb3
institution DOAJ
issn 1743-7075
language English
publishDate 2024-11-01
publisher BMC
record_format Article
series Nutrition & Metabolism
spelling doaj-art-cbd9ac043ef2425896d4bcfb865eeeb32025-08-20T02:49:56ZengBMCNutrition & Metabolism1743-70752024-11-0121111310.1186/s12986-024-00866-0LncRNA mediated metabolic reprogramming: the chief culprits of solid tumor malignant progression: an update reviewKun Fang0Huizhe Xu1Shuai Yuan2Xiaoxi Li3Xiaoyu Chen4Xiushi Fan5Xiaoxin Gao6Lu Zhang7Shulan Sun8Xudong Zhu9Central Laboratory, Cancer Hospital of Dalian University of Technology, Cancer Hospital of China Medical University, Liaoning Cancer Hospital & InstituteCentral Laboratory, Cancer Hospital of Dalian University of Technology, Cancer Hospital of China Medical University, Liaoning Cancer Hospital & InstituteCentral Laboratory, Cancer Hospital of Dalian University of Technology, Cancer Hospital of China Medical University, Liaoning Cancer Hospital & InstituteCentral Laboratory, Cancer Hospital of Dalian University of Technology, Cancer Hospital of China Medical University, Liaoning Cancer Hospital & InstituteCentral Laboratory, Cancer Hospital of Dalian University of Technology, Cancer Hospital of China Medical University, Liaoning Cancer Hospital & InstituteCentral Laboratory, Cancer Hospital of Dalian University of Technology, Cancer Hospital of China Medical University, Liaoning Cancer Hospital & InstituteCentral Laboratory, Cancer Hospital of Dalian University of Technology, Cancer Hospital of China Medical University, Liaoning Cancer Hospital & InstituteDepartment of Human Resources, Cancer Hospital of Dalian University of Technology, Cancer Hospital of China Medical University, Liaoning Cancer Hospital & InstituteCentral Laboratory, Cancer Hospital of Dalian University of Technology, Cancer Hospital of China Medical University, Liaoning Cancer Hospital & InstituteDepartment of General Surgery, Cancer Hospital of Dalian University of Technology, Cancer Hospital of China Medical University, Liaoning Cancer Hospital & InstituteAbstract Metabolism reprogramming (MR) is one of the top ten hallmarks of malignant tumors. The aberrant activation of MR has been recognized as a critical contributory factor to the malignant progression of solid tumors. Moreover, various long non-coding RNAs (lncRNAs) are implicated in the aberrant activation of MR in solid tumor cells. Therefore, in this review, we mainly focus on summarizing the functional relevance and molecular mechanistic underpinnings of lncRNAs in modulating MR of solid tumors by targeting glucose metabolism, lipid metabolism, affecting mitochondrial function, and regulating interactions between tumor and non-tumor cells in tumor microenvironment. Besides, we also underscore the potential for constructing lncRNAs-centered tumor metabolic regulation networks and developing novel anti-tumor strategies by targeting lncRNAs and abnormal MR. Ultimately, this review seeks to offer new targets and avenues for the clinical treatment of solid tumors in the future.https://doi.org/10.1186/s12986-024-00866-0Long non-coding RNAMetabolic reprogrammingSolid tumorsTherapeutic targets
spellingShingle Kun Fang
Huizhe Xu
Shuai Yuan
Xiaoxi Li
Xiaoyu Chen
Xiushi Fan
Xiaoxin Gao
Lu Zhang
Shulan Sun
Xudong Zhu
LncRNA mediated metabolic reprogramming: the chief culprits of solid tumor malignant progression: an update review
Nutrition & Metabolism
Long non-coding RNA
Metabolic reprogramming
Solid tumors
Therapeutic targets
title LncRNA mediated metabolic reprogramming: the chief culprits of solid tumor malignant progression: an update review
title_full LncRNA mediated metabolic reprogramming: the chief culprits of solid tumor malignant progression: an update review
title_fullStr LncRNA mediated metabolic reprogramming: the chief culprits of solid tumor malignant progression: an update review
title_full_unstemmed LncRNA mediated metabolic reprogramming: the chief culprits of solid tumor malignant progression: an update review
title_short LncRNA mediated metabolic reprogramming: the chief culprits of solid tumor malignant progression: an update review
title_sort lncrna mediated metabolic reprogramming the chief culprits of solid tumor malignant progression an update review
topic Long non-coding RNA
Metabolic reprogramming
Solid tumors
Therapeutic targets
url https://doi.org/10.1186/s12986-024-00866-0
work_keys_str_mv AT kunfang lncrnamediatedmetabolicreprogrammingthechiefculpritsofsolidtumormalignantprogressionanupdatereview
AT huizhexu lncrnamediatedmetabolicreprogrammingthechiefculpritsofsolidtumormalignantprogressionanupdatereview
AT shuaiyuan lncrnamediatedmetabolicreprogrammingthechiefculpritsofsolidtumormalignantprogressionanupdatereview
AT xiaoxili lncrnamediatedmetabolicreprogrammingthechiefculpritsofsolidtumormalignantprogressionanupdatereview
AT xiaoyuchen lncrnamediatedmetabolicreprogrammingthechiefculpritsofsolidtumormalignantprogressionanupdatereview
AT xiushifan lncrnamediatedmetabolicreprogrammingthechiefculpritsofsolidtumormalignantprogressionanupdatereview
AT xiaoxingao lncrnamediatedmetabolicreprogrammingthechiefculpritsofsolidtumormalignantprogressionanupdatereview
AT luzhang lncrnamediatedmetabolicreprogrammingthechiefculpritsofsolidtumormalignantprogressionanupdatereview
AT shulansun lncrnamediatedmetabolicreprogrammingthechiefculpritsofsolidtumormalignantprogressionanupdatereview
AT xudongzhu lncrnamediatedmetabolicreprogrammingthechiefculpritsofsolidtumormalignantprogressionanupdatereview